Researchers are working on a redesigned pump that could offer hope for those with HFpEF, which accounts for about 32 million heart failure cases globally.

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a "polypill" combination of three ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for ...

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.

NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

Roth Capital Markets analyst Jonathan Aschoff has maintained his “Buy” rating and US$30.00 price target on Tenax Therapeutics ...

The answer is very clear that if you have MI and preserved EF, there is no benefit of using a beta-blocker. Sripal Bangalore ...

New findings reveal sotagliflozin's benefits for patients with heart failure with preserved ejection fraction without ...

A once-daily polypill containing 3 guideline-directed therapies for heart failure with reduced ejection fraction (HFrEF) led ...

A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...

Trastuzumab emtansine is linked to a lower incidence of decrease in left ventricular ejection fraction than other trastuzumab ...